Deutsche Bank AG has reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 12.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,990,557 shares of the company's stock after selling 1,179,333 shares during the period. Deutsche Bank AG owned 0.34% of Procter & Gamble worth $1,361,751,000 as of its most recent SEC filing.\n\nGAMMA Investing LLC significantly increased its position in shares of Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after buying an additional 7,913,335 shares in the last quarter.\n\nCapital Research Global Investors grew its position in shares of Procter & Gamble by 62.5% during the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock worth $1,240,294,000 after buying an additional 2,846,560 shares in the last quarter.\n\nNorthern Trust Corp grew its position in shares of Procter & Gamble by 10.1% during the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after buying an additional 2,703,757 shares in the last quarter.\n\nUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, grew its position in shares of Procter & Gamble by 15.8% during the fourth quarter. UBS AM now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after buying an additional 2,224,912 shares in the last quarter.\n\nUniversal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Procter & Gamble during the fourth quarter worth approximately $310,679,000.\n\nInstitutional investors and hedge funds own 65.77% of the company's stock.\n\nProcter & Gamble traded up $1.34 during mid-day trading on Monday, hitting $154.85. 2,303,226 shares of the stock were exchanged, compared to its average volume of 8,181,113. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The business has a fifty day moving average price of $158.26 and a 200 day moving average price of $163.66. The stock has a market capitalization of $362.70 billion, a price-to-earnings ratio of 23.77, a PEG ratio of 4.05 and a beta of 0.37.\n\nProcter & Gamble last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%. Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.40 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.\n\nThe business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's payout ratio is presently 64.98%.\n\nAnalyst Ratings Changes: PG has been the topic of a number of recent research reports. JPMorgan Chase & Co. reiterated a 'neutral' rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Redburn Atlantic downgraded Procter & Gamble from a 'buy' rating to a 'neutral' rating and set a $161.00 price objective on the stock in a report on Thursday, May 1st. Morgan Stanley set a $180.00 price target on Procter & Gamble and gave the company an 'overweight' rating in a research note on Friday, April 25th. Barclays set a $164.00 price target on Procter & Gamble and gave the stock an 'equal weight' rating in a report on Thursday, July 31st. Finally, Truist Financial dropped their price objective on Procter & Gamble from $185.00 to $180.00 and set a 'buy' rating for the company in a research note on Friday, April 25th. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of 'Moderate Buy' and a consensus price target of $175.88.\n\nProcter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Deutsche Bank AG Has $1.36 Billion Stock Holdings in Procter & Gamble Company (The) (NYSE:PG)

Deutsche Bank AG reduced its stake in Procter & Gamble by 12.9% in the first quarter, selling 1.179 million shares and now holding 7.99 million shares worth $1.36 billion. GAMMA Investing LLC significantly increased its position by 20,758.5%, acquiring 7.91 million shares worth $1.355 billion. Capital Research Global Investors grew its holdings by 62.5%, now owning 7.4 million shares worth $1.24 billion. Northern Trust Corp increased its stake by 10.1%, now holding 29.4 million shares worth $4.93 billion. UBS AM grew its position by 15.8%, now owning 16.3 million shares worth $2.73 billion. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake worth $310.7 million. Institutional investors and hedge funds collectively own 65.77% of Procter & Gamble's stock. The company reported Q2 earnings of $1.48 EPS, beating estimates, with $20.89 billion in revenue and a 1.7% year-over-year increase. It announced a $1.0568 per share dividend, with a yield of 2.7%, and has a market cap of $362.7 billion. Analyst ratings remain mixed, with Morgan Stanley and Barclays maintaining positive views, while Redburn Atlantic downgraded the stock to neutral.